ArticleJournal of endocrinological investigation2026
The association of high-sensitivity C-reactive protein levels and their changes with heart failure in Chinese diabetes patients.
Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo investigate the associations of baseline high-sensitivity C-reactive protein (hs-CRP), hs-CRP trajectories, and cumulative hs-CRP (CumCRP) exposure with the risk of incident heart failure (HF) in individuals with diabetes.
methodsWe analyzed 18,269 patients with diabetes from the Kailuan Study who were free of HF and cancer at baseline (2006-2012). Baseline hs-CRP was categorized into quartiles (Q1-Q4), with a separate group for hs-CRP values > 20 mg/L. Repeated measurements were used to identify long-term trajectories via group-based trajectory modelling and calculate time-weighted cumulative hs-CRP after excluding participants with hs-CRP > 20 mg/L. Fine-Gray subdistribution hazard models were employed to estimate adjusted hazard ratios (HRs) for incident HF.
resultsOver a mean follow-up of 9.66 ± 2.85 years, 826 HF occurred. Compared with baseline hs-CRP quartile (Q1), the HRs for HF increased across higher quartiles and in the > 20 mg/L group were 1.22 (95% CI 0.98-1.52) for Q2, 1.25 (1.00-1.55) for Q3, 1.42 (1.15-1.76) for Q4, and 1.68 (1.24-2.28) for hs-CRP > 20 mg/L group. In longitudinal analyses, the high-decreased (HR:1.65; 95% CI:1.32-2.06) and moderate-fluctuated (HR:1.48; 95% CI:1.07-2.04) trajectories were associated with significantly higher HF risk than the low-stable pattern. Similarly, the highest CumCRP quartiles were associated with increased HF risk with HR (95% CI) of 1.33 (1.08-1.64) for Q3, and 1.47 (1.19-1.82) for Q4 compared to Q1.
conclusionsIn this large cohort of patients with diabetes, higher baseline hs-CRP, greater cumulative hs-CRP exposure, and hs-CRP trajectories characterized by earlier elevation were independently associated with increased risk of incident HF. These findings highlight the importance of monitoring long-term inflammatory burden for HF risk stratification in diabetes.
Indexed as
Identifiers
42287531What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.